Search…

    Saved articles

    You have not yet added any article to your bookmarks.

    Browse articles

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Merck Cuts 2025 Outlook on Tariffs, Charges

    2 days ago

    4

    0

    Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.
    Click here to Read more
    Prev Article
    U.K. Risks Higher Inflation if It Retaliates Against Tariffs, BOE’s Bailey Warns
    Next Article
    Researchers identify two new crocodile species

    Related Health Updates:

    Comments (0)

      Leave a Comment